Report overview
Molecular diagnosis of tumor refers to the molecular biological diagnosis technology with nucleic acid or protein as the core, which is an important method for early diagnosis of tumor.
This report contains market size and forecasts of Oncology Based Molecular Diagnostics in global, including the following market information:
Global Oncology Based Molecular Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Oncology Based Molecular Diagnostics Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Oncology Based Molecular Diagnostics companies in 2021 (%)
The global Oncology Based Molecular Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PCR Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oncology Based Molecular Diagnostics include Abbott Laboratories, Bayer Healthcare, Becton Dickinson, Cepheid, Dako, Danaher Corporation, Gen Probe(Hologic), Roche Diagnostics and Siemens Healthcare. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oncology Based Molecular Diagnostics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncology Based Molecular Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Oncology Based Molecular Diagnostics Market Segment Percentages, by Type, 2021 (%)
PCR
Multiplex PCR
In Situ Hybridization
Isothermal Nucleic Acid Amplification Technology (INAAT)
Global Oncology Based Molecular Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Oncology Based Molecular Diagnostics Market Segment Percentages, by Application, 2021 (%)
Breast Cancer
Prostate Cancer
Colorectal Cancer
Cervical Cancer
Other
Global Oncology Based Molecular Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Oncology Based Molecular Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncology Based Molecular Diagnostics revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Oncology Based Molecular Diagnostics revenues share in global market, 2021 (%)
Key companies Oncology Based Molecular Diagnostics sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Oncology Based Molecular Diagnostics sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Bayer Healthcare
Becton Dickinson
Cepheid
Dako
Danaher Corporation
Gen Probe(Hologic)
Roche Diagnostics
Siemens Healthcare
